High plasma galectin-1 level has been reported to be a significant predictor of renal function decline, independently of diabetes and other risk factors, in a longitudinal study of 798 individuals who underwent elective coronary angiography or percutaneous coronary intervention. This evidence concerns the gene LGALS1 and diabetes mellitus.